Jing Lin - Granger IN, US Fu Hsiung Tsai - Mishawaka IN, US Huan-Ping Wu - Granger IN, US Nicole D. Ellis - Mishawaka IN, US Henry C. Arndt - Elkhart IN, US
Assignee:
Bayer Healthcare LLC - Tarrytown NY
International Classification:
G01N 27/327 G01N 33/96
US Classification:
205792, 20440301, 2057775
Abstract:
A method of distinguishing a control solution from a sample in an electrochemical test sensor is performed. The method includes adding a control marker to the control solution. The control solution includes the control marker and analyte. The test sensor includes working and counter electrodes, and a reagent. A potential is applied to the test sensor to oxidize the control marker and the analyte. The resulting electrical current is measured. A potential is applied to the test sensor lower than the other potential in which the potential is sufficient to oxidize the analyte and not the control marker. The resulting electrical current is measured. Determining whether a control solution or a sample is present based on the measured electrical currents. To increase the measured current, a salt may be added to the control solution in an amount sufficient to increase the electrical current by at least 5% as compared to a control solution in the absence of a salt.
Correction Of Oxygen Effect In Test Sensor Using Reagents
An electrochemical test sensor is adapted to measure glucose and correct for the oxygen effect in a fluid sample. The test sensor comprises a base, first and second working electrodes, and a counter electrode. The first working electrode includes glucose oxidase, a mediator and peroxidase. The second working electrode includes glucose oxidase and the mediator. The first working electrode, the second working electrode and the counter electrode are located on the base. In other embodiments, an electrochemical test sensor is adapted to measure cholesterol, lactate, pyruvate or xanthine and correct for the oxygen effect in a fluid sample.
Jacob S. Brauer - Chicago IL, US Darren Brown - Harrison NY, US Kevin Chang - Granger IN, US Jun Chen - Warren NJ, US Richard Kates - Ridgewood NJ, US Jennifer M. Levin - Chicago IL, US Harris Lieber - White Plains NY, US Jing Lin - Granger IN, US Dawn Rountree - Derby CT, US Amy Schwartz - Evanston IL, US Fred Sommer - Ardsley NY, US Fu Hsiung Tsai - Mishawaka IN, US Huan-Ping Wu - Granger IN, US Raymond Yao - Tarrytown NY, US
International Classification:
C12Q 1/54 C12M 1/34
US Classification:
435 14, 4352871
Abstract:
A testing system for testing an analyte in a fluid sample includes a user interface including a display for displaying information relating to measurements of health data and an input device for receiving information from a user relating to the health data. The testing system further includes an automarking feature adapted to identify a testing result of a control solution, the testing of the control solution being distinguishable from the testing of the fluid sample. The testing result of the control solution is not included in the information relating to the measurements of health data that is displayed to a user via the user interface.
Method Of Correcting For Oxygen Effect On Test Sensors
An electrochemical test sensor is adapted to measure glucose and correct for the oxygen effect in a fluid sample. The test sensor comprises a base, first and second working electrodes, and a counter electrode. The first working electrode includes glucose oxidase, a mediator and peroxidase. The second working electrode includes glucose oxidase and the mediator. The first working electrode, the second working electrode and the counter electrode are located on the base. In other embodiments, an electrochemical test sensor is adapted to measure cholesterol, lactate, pyruvate or xanthine and correct for the oxygen effect in a fluid sample.
Method Of Correcting For Oxygen Effect On Test Sensors
An electrochemical test sensor is adapted to measure glucose and correct for the oxygen effect in a fluid sample. The test sensor comprises a base, first and second working electrodes, and a counter electrode. The first working electrode includes glucose oxidase, a mediator and peroxidase. The second working electrode includes glucose oxidase and the mediator. The first working electrode, the second working electrode and the counter electrode are located on the base. In other embodiments, an electrochemical test sensor is adapted to measure cholesterol, lactate, pyruvate or xanthine and correct for the oxygen effect in a fluid sample.
Methods Of Treating Central Nervous System Disorders
Provided herein are methods of treating central nervous system (CNS) disorders (e.g., Binge Eating Disorder (BED), Attention-Deficit/Hyperactivity Disorder (ADHD), etc.) with a dasotraline therapy while avoiding adverse drug interactions.
An electrochemical test sensor is adapted to measure glucose and correct for the oxygen effect in a fluid sample. The test sensor comprises a base, first and second working electrodes, and a counter electrode. The first working electrode includes glucose oxidase, a mediator and peroxidase. The second working electrode includes glucose oxidase and the mediator. The first working electrode, the second working electrode and the counter electrode are located on the base. In other embodiments, an electrochemical test sensor is adapted to measure cholesterol, lactate, pyruvate or xanthine and correct for the oxygen effect in a fluid sample.
Newborn Medicine AssociatesMount Sinai Hospital Newborn Medicine 1184 5 Ave STE 341, New York, NY 10029 2122415446 (phone), 2125345207 (fax)
Education:
Medical School Wenzhou Med Coll, Wenzhou, Zhejiang, China Graduated: 1983
Languages:
English Spanish
Description:
Dr. Lin graduated from the Wenzhou Med Coll, Wenzhou, Zhejiang, China in 1983. He works in New York, NY and specializes in Neonatal-Perinatal Medicine. Dr. Lin is affiliated with Mount Sinai Medical Center.